Atlas Trials

A Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer.

Clinical trial NCT05917470 · TERMINATED

Trial details

NCT number
NCT05917470
Sponsor
Oncternal Therapeutics, Inc
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metastatic Castration-resistant Prostate Cancer
Start date
2023-09-20
Primary completion
2024-09-12
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.